Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation

被引:234
作者
Delvecchio, Manuela [1 ,2 ]
Gaucher, Jonathan [1 ,2 ]
Aguilar-Gurrieri, Carmen [1 ,2 ]
Ortega, Esther [1 ,2 ]
Panne, Daniel [1 ,2 ]
机构
[1] European Mol Biol Lab, F-38042 Grenoble, France
[2] Univ Grenoble Alpes, European Mol Biol Lab, CNRS, Unit Virus Host Cell Interact, Grenoble, France
关键词
PHD FINGER; ACETYLTRANSFERASE DOMAIN; TRANSCRIPTIONAL COACTIVATOR; HISTONE RECOGNITION; DNA-BINDING; CBP; ACETYLATION; BROMODOMAIN; ACTIVATION; P53;
D O I
10.1038/nsmb.2642
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
CBP and p300 are histone acetyltransferases (HATs) that associate with and acetylate transcriptional regulators and chromatin. Mutations in their catalytic 'cores' are linked to genetic disorders, including cancer. Here we present the 2.8-angstrom crystal structure of the catalytic core of human p300 containing its bromodomain, CH2 region and HAT domain. The structure reveals that the CH2 region contains a discontinuous PHD domain interrupted by a RING domain. The bromodomain, PHD, RING and HAT domains adopt an assembled configuration with the RING domain positioned over the HAT substrate-binding pocket. Disease mutations that disrupt RING attachment led to upregulation of HAT activity, thus revealing an inhibitory role for this domain. The structure provides a starting point for understanding how chromatin-substrate targeting and HAT regulation are coupled and why mutations in the p300 core lead to dysregulation.
引用
收藏
页码:1040 / +
页数:9
相关论文
共 36 条
[1]
Is histone acetylation the most important physiological function for CBP and p300? [J].
Bedford, David C. ;
Brindle, Paul K. .
AGING-US, 2012, 4 (04) :247-255
[2]
The SIRT2 Deacetylase Regulates Autoacetylation of p300 [J].
Black, Joshua C. ;
Mosley, Amber ;
Kitada, Tasuku ;
Washburn, Michael ;
Carey, Michael .
MOLECULAR CELL, 2008, 32 (03) :449-455
[3]
Functional analysis of the p300 acetyltransferase domain:: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity [J].
Bordoli, L ;
Hüsser, S ;
Lüthi, U ;
Netsch, M ;
Osmani, H ;
Eckner, R .
NUCLEIC ACIDS RESEARCH, 2001, 29 (21) :4462-4471
[4]
RING Domain E3 Ubiquitin Ligases [J].
Deshaies, Raymond J. ;
Joazeiro, Claudio A. P. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 :399-434
[5]
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family [J].
Filippakopoulos, Panagis ;
Picaud, Sarah ;
Mangos, Maria ;
Keates, Tracy ;
Lambert, Jean-Philippe ;
Barsyte-Lovejoy, Dalia ;
Felletar, Ildiko ;
Volkmer, Rudolf ;
Mueller, Susanne ;
Pawson, Tony ;
Gingras, Anne-Claude ;
Arrowsmith, Cheryl H. ;
Knapp, Stefan .
CELL, 2012, 149 (01) :214-231
[6]
Mutations truncating the EP300 acetylase in human cancers [J].
Gayther, SA ;
Batley, SJ ;
Linger, L ;
Bannister, A ;
Thorpe, K ;
Chin, SF ;
Daigo, Y ;
Russell, P ;
Wilson, A ;
Sowter, HM ;
Delhanty, JDA ;
Ponder, BAJ ;
Kouzarides, T ;
Caldas, C .
NATURE GENETICS, 2000, 24 (03) :300-303
[7]
Goodman RH, 2000, GENE DEV, V14, P1553
[8]
Polyubiquitination of p53 by a ubiquitin ligase activity of p300 [J].
Grossman, SR ;
Deato, ME ;
Brignone, C ;
Chan, HM ;
Kung, AL ;
Tagami, H ;
Nakatani, Y ;
Livingston, DM .
SCIENCE, 2003, 300 (5617) :342-344
[9]
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain [J].
Gu, W ;
Roeder, RG .
CELL, 1997, 90 (04) :595-606
[10]
Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome [J].
Kalkhoven, E ;
Roelfsema, JH ;
Teunissen, H ;
den Boer, A ;
Ariyurek, Y ;
Zantema, A ;
Breuning, MH ;
Hennekam, RCM ;
Peters, DJM .
HUMAN MOLECULAR GENETICS, 2003, 12 (04) :441-450